{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:16:08Z","timestamp":1792368968510,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.anai.2025.12.016","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T22:40:13Z","timestamp":1766356813000},"page":"545-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Relative particle size and distribution of inhaled triple therapies"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8140-2014","authenticated-orcid":false,"given":"Brian","family":"Lipworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Zambelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Agazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Piraino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.anai.2025.12.016_bib0001","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S2213-2600(14)70103-1","article-title":"Unlocking the quiet zone: the small airway asthma phenotype","volume":"2","author":"Lipworth","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.anai.2025.12.016_bib0002","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S2213-2600(19)30049-9","article-title":"Exploring the relevance and extent of small airways dysfunction in asthma (Atlantis): baseline data from a prospective cohort study","volume":"7","author":"Postma","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.anai.2025.12.016_bib0003","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.anai.2012.06.022","article-title":"Are we overlooking persistent small airways dysfunction in community-managed asthma?","volume":"109","author":"Anderson","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.12.016_bib0004","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000452479","article-title":"Prevalence of small-airway dysfunction among COPD patients with different gold stages and its role in the impact of disease","volume":"93","author":"Crisafulli","year":"2017","journal-title":"Respiration"},{"issue":"2","key":"10.1016\/j.anai.2025.12.016_bib0005","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/07853890.2011.585656","article-title":"Assessing and treating small airways disease in asthma and chronic obstructive pulmonary disease","volume":"44","author":"Usmani","year":"2012","journal-title":"Ann Med"},{"issue":"6","key":"10.1016\/j.anai.2025.12.016_bib0006","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.jaci.2013.03.009","article-title":"Alveolar nitric oxide and asthma control in mild untreated asthma","volume":"131","author":"Scichilone","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.12.016_bib0007","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.anai.2022.09.026","article-title":"Airflow obstruction in real life is associated with small airways dysfunction in moderate-to-severe asthma","volume":"129","author":"Chan","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.12.016_bib0008","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00543-2022","article-title":"Interactions between spirometry and oscillometry in patients with moderate to severe asthma","volume":"60","author":"Chan","year":"2022","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.anai.2025.12.016_bib0009","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000242113","article-title":"Relationship between small airway function and health status, dyspnea and disease control in asthma","volume":"80","author":"Takeda","year":"2010","journal-title":"Respiration"},{"issue":"6","key":"10.1016\/j.anai.2025.12.016_bib0010","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1164\/ajrccm.161.6.9906075","article-title":"Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes","volume":"161","author":"\u2019t Veen","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.anai.2025.12.016_bib0011","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.chest.2021.03.047","article-title":"Seven pillars of small airways disease in asthma and COPD \u2013 supporting opportunities for novel therapies","volume":"160","author":"Usmani","year":"2021","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.anai.2025.12.016_bib0012","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1164\/ajrccm.154.5.8912772","article-title":"Alveolar tissue inflammation in asthma","volume":"154","author":"Kraft","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.anai.2025.12.016_bib0013","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1183\/09031936.00082314","article-title":"Small airway dysfunction is associated with poorer asthma control","volume":"44","author":"Manoharan","year":"2014","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.anai.2025.12.016_bib0014","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1016\/j.jaip.2020.07.031","article-title":"Impulse oscillometry bronchodilator response and asthma control","volume":"8","author":"Kuo","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.anai.2025.12.016_bib0015","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/cea.14525","article-title":"Fractional exhaled nitric oxide identifies worse outcomes in asthmatics with mucus plugging and bronchial wall thickening","volume":"54","author":"Chan","year":"2024","journal-title":"Clin Exp Allergy"},{"issue":"10","key":"10.1016\/j.anai.2025.12.016_bib0016","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.jaip.2022.06.042","article-title":"Determinants of asthma control and exacerbations in moderate to severe asthma","volume":"10","author":"Chan","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2025.12.016_bib0017","first-page":"339","article-title":"Asthma symptoms do not predict spirometry","volume":"14","author":"Cowie","year":"2007","journal-title":"Can Respir J"},{"issue":"3","key":"10.1016\/j.anai.2025.12.016_bib0018","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.anai.2019.12.017","article-title":"Airwave oscillometry and patient-reported outcomes in persistent asthma","volume":"124","author":"Kuo","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"10","key":"10.1016\/j.anai.2025.12.016_bib0019","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/j.jaip.2025.07.002","article-title":"Small airway dysfunction is an independent exacerbation risk biomarker in the mild, well-controlled asthmatic; a frequently unrecognized high-risk phenotype","volume":"13","author":"Galant","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2025.12.016_bib0020","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1152\/jappl.1992.72.3.1016","article-title":"Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure","volume":"72","author":"Yanai","year":"1992","journal-title":"J Appl Physiol"},{"issue":"5","key":"10.1016\/j.anai.2025.12.016_bib0021","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1378\/chest.12-1766","article-title":"Small airway obstruction in COPD: new insights based on micro-CT imaging and MRI imaging","volume":"143","author":"Hogg","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.anai.2025.12.016_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2024.107915","article-title":"Reversibility of airwave oscillometry in COPD","volume":"236","author":"Greig","year":"2025","journal-title":"Respir Med"},{"issue":"7","key":"10.1016\/j.anai.2025.12.016_bib0023","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/17476348.2024.2380070","article-title":"Small airways disease in chronic obstructive pulmonary disease","volume":"18","author":"Lazarinis","year":"2024","journal-title":"Expert Rev Respir Med"},{"issue":"6","key":"10.1016\/j.anai.2025.12.016_bib0024","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.jaci.2016.11.036","article-title":"Does size really matter?: relationship of particle size to lung deposition and exhaled fraction","volume":"139","author":"Jabbal","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2025.12.016_bib0025","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3390\/pharmaceutics16101334","article-title":"In vitro analysis of aerodynamic properties and co-deposition of a fixed-dose combination of fluticasone furoate, umeclidinium bromide, and vilanterol trifenatate","volume":"16","author":"Maneechotesuwan","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.anai.2025.12.016_bib0026","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/jamp.2021.0061","article-title":"In vitro drug delivery of a fixed-dose combination of fluticasone furoate\/umeclidinium\/vilanterol from a dry powder inhaler","volume":"36","author":"Hamilton","year":"2023","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"3","key":"10.1016\/j.anai.2025.12.016_bib0027","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/089426803769017659","article-title":"Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part I: design","volume":"16","author":"Marple","year":"2004","journal-title":"J Aerosol Med"},{"key":"10.1016\/j.anai.2025.12.016_bib0028","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention. Accessed December 18, 2025. Available at: https:\/\/ginasthma.org\/"},{"key":"10.1016\/j.anai.2025.12.016_bib0029","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Accessed December 18, 2025. Available at: https:\/\/goldcopd.org"},{"issue":"1-2","key":"10.1016\/j.anai.2025.12.016_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13556-013-0006-6","article-title":"Foster\u00ae: a high-efficiency combination metered dose inhaler with consistent particle size distribution at alternative flow rates","volume":"4","author":"De Maria","year":"2014","journal-title":"Comb Prod Ther"},{"issue":"3","key":"10.1016\/j.anai.2025.12.016_bib0031","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1089\/jamp.2020.1601","article-title":"Predicting lung deposition of extrafine inhaled corticosteroid-containing fixed combinations in patients with chronic obstructive pulmonary disease using functional respiratory imaging: an in silico study","volume":"34","author":"Usmani","year":"2021","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"4","key":"10.1016\/j.anai.2025.12.016_bib0032","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/jamp.2021.0046","article-title":"Lung deposition of inhaled extrafine beclomethasone dipropionate\/formoterol fumarate\/glycopyrronium bromide in healthy volunteers and asthma: the STORM Study","volume":"35","author":"Usmani","year":"2022","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.anai.2025.12.016_bib0033","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.2147\/COPD.S510214","article-title":"In silico lung deposition profiles of three single-inhaler triple therapies in patients with COPD using functional respiratory imaging","volume":"20","author":"Singh","year":"2025","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"10.1016\/j.anai.2025.12.016_bib0034","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12931-021-01813-w","article-title":"A scintigraphy study of budesonide\/glycopyrrolate\/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease","volume":"22","author":"Usmani","year":"2021","journal-title":"Respir Res"},{"issue":"5","key":"10.1016\/j.anai.2025.12.016_bib0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2500\/aap.2010.31.3367","article-title":"Both bronchial and alveolar exhaled nitric oxide are reduced with extrafine beclomethasone dipropionate in asthma","volume":"31","author":"Nicolini","year":"2010","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"10.1016\/j.anai.2025.12.016_bib0036","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.pupt.2009.01.005","article-title":"Effect of inhaled corticosteroids on small airways in asthma: investigation using impulse oscillometry","volume":"22","author":"Yamaguchi","year":"2009","journal-title":"Pulm Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.anai.2025.12.016_bib0037","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1016\/S0091-6749(99)70043-6","article-title":"Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography","volume":"104","author":"Goldin","year":"1999","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.12.016_bib0038","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12890-016-0348-4","article-title":"Effect of inhaled corticosteroid particle size on asthma efficacy and safety outcomes: a systematic literature review and meta-analysis","volume":"17","author":"El Baou","year":"2017","journal-title":"BMC Pulm Med"},{"issue":"3","key":"10.1016\/j.anai.2025.12.016_bib0039","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3904\/kjim.2024.393","article-title":"Comparison of extrafine and non-extrafine inhaled corticosteroids\/long-acting \u03b22-agonists as maintenance and reliever therapy in asthma: a randomized open-label crossover trial","volume":"40","author":"Lee","year":"2025","journal-title":"Korean J Intern Med"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625013912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625013912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:32:38Z","timestamp":1778797958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120625013912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1081120625013912"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2025.12.016","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relative particle size and distribution of inhaled triple therapies","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2025.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}